Found: 12
Select item for more details and to access through your institution.
Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4460, doi. 10.3390/ijms22094460
- By:
- Publication type:
- Article
ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 23, p. 5886, doi. 10.3390/ijms20235886
- By:
- Publication type:
- Article
The TrkAIII Oncoprotein Inhibits Mitochondrial Free Radical ROS-Induced Death of SH-SY5Y Neuroblastoma Cells by Augmenting SOD2 Expression and Activity at the Mitochondria, within the Context of a Tumour Stem Cell-like Phenotype.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094568
- By:
- Publication type:
- Article
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 831, doi. 10.1007/s00262-020-02769-4
- By:
- Publication type:
- Article
Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6156, doi. 10.3390/cancers13246156
- By:
- Publication type:
- Article
Revisiting the Immunological Aspects of Temozolomide Considering the Genetic Landscape and the Immune Microenvironment Composition of Glioblastoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.747690
- By:
- Publication type:
- Article
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 430, p. 1, doi. 10.1126/scitranslmed.aao2731
- By:
- Publication type:
- Article
Altered function of the glutamate–aspartate transporter GLAST, a potential therapeutic target in glioblastoma.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 10, p. 2539, doi. 10.1002/ijc.31985
- By:
- Publication type:
- Article
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin
- Published in:
- FEBS Letters, 2012, v. 586, n. 20, p. 3681, doi. 10.1016/j.febslet.2012.08.026
- By:
- Publication type:
- Article
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain
- Published in:
- FEBS Letters, 2012, v. 586, n. 16, p. 2366, doi. 10.1016/j.febslet.2012.05.048
- By:
- Publication type:
- Article
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells
- Published in:
- FEBS Letters, 2011, v. 585, n. 20, p. 3328, doi. 10.1016/j.febslet.2011.09.023
- By:
- Publication type:
- Article
TrkAIII Promotes Microtubule Nucleation and Assembly at the Centrosome in SH-SY5Y Neuroblastoma Cells, Contributing to an Undifferentiated Anaplastic Phenotype.
- Published in:
- BioMed Research International, 2013, v. 2013, p. 1, doi. 10.1155/2013/740187
- By:
- Publication type:
- Article